C4 Therapeutics to Participate in Upcoming September Investor Conferences

Rhea-AI Summary

C4 Therapeutics (Nasdaq: CCCC), a clinical-stage biopharmaceutical company focused on targeted protein degradation, has announced its participation in two upcoming investor conferences in September 2024. The company's management will engage in fireside chats at the following events:

• Wells Fargo Healthcare Conference in Boston, MA on September 5, 2024, at 8:45 AM ET
• 2024 Cantor Global Healthcare Conference in New York, NY on September 18, 2024, at 8:35 AM ET

Both events will feature live webcasts accessible through C4 Therapeutics' website, with archived replays available for approximately 30 days after the live events.

WATERTOWN, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in fireside chats at two September investor conferences.

Fireside Chat Details:

Event: Wells Fargo Healthcare Conference taking place in Boston, MA
Date/Time: September 5, 2024 at 8:45 AM ET

Event: 2024 Cantor Global Healthcare Conference taking place in New York, New York
Date/Time: September 18, 2024 at 8:35 AM ET

Live webcasts will be available on the Investors section of the company’s website at www.c4therapeutics.com. Archived replays of the webcasts will be available for approximately 30 days following the live events.

About C4 Therapeutics
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO^® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit www.c4therapeutics.com.

Contacts:
Investors:
Courtney Solberg
Senior Manager, Investor Relations
CSolberg@c4therapeutics.com

Media:
Loraine Spreen
Senior Director, Corporate Communications & Patient Advocacy
LSpreen@c4therapeutics.com

FAQ

What investor conferences will C4 Therapeutics (CCCC) participate in during September 2024?

C4 Therapeutics will participate in two investor conferences in September 2024: the Wells Fargo Healthcare Conference in Boston on September 5, and the 2024 Cantor Global Healthcare Conference in New York on September 18.

When and where is the Wells Fargo Healthcare Conference that C4 Therapeutics (CCCC) will attend?

The Wells Fargo Healthcare Conference, which C4 Therapeutics will attend, is taking place in Boston, MA on September 5, 2024. C4T management will participate in a fireside chat at 8:45 AM ET.

What is the date and location of the 2024 Cantor Global Healthcare Conference where C4 Therapeutics (CCCC) will present?

C4 Therapeutics will present at the 2024 Cantor Global Healthcare Conference on September 18, 2024, at 8:35 AM ET. The conference is taking place in New York, New York.

How can investors access the webcasts of C4 Therapeutics (CCCC) presentations at the September 2024 conferences?

Investors can access live webcasts of C4 Therapeutics' presentations through the Investors section of the company's website at www.c4therapeutics.com. Archived replays will be available for approximately 30 days following the live events.